Carole Decker1, Linda Garavalia2, Brian Garavalia3, Elizabeth Gialde3, Robert W Yeh4, John Spertus1, Adnan K Chhatriwalla5. 1. Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO. 2. University of Missouri-Kansas City, Kansas City, MO. 3. Saint Luke's Mid America Heart Institute, Kansas City, MO. 4. Massachusetts General Hospital, Boston, MA. 5. Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO. Electronic address: achhatriwalla@saint-lukes.org.
Abstract
BACKGROUND: The foundation of precision medicine is the ability to tailor therapy based upon the expected risks and benefits of treatment for each individual patient. In a prior study, we implemented a software platform, ePRISM, to execute validated risk-stratification models for patients undergoing percutaneous coronary intervention and found substantial variability in the use of the personalized estimates to tailor care. A better understanding of physicians' perspectives about the use of individualized risk-estimates is needed to overcome barriers to their adoption. METHODS: In a qualitative research study, we conducted interviews, in-person or by telephone, with 27 physicians at 8 centers that used ePRISM until thematic saturation occurred. Data were coded using descriptive content analyses. RESULTS: Three major themes emerged among physicians who did not use ePRISM to support decision making: (1) "Experience versus Evidence," physicians' preference to rely upon personal experience and subjective assessments rather than objective risk estimates; (2) "Omission of Therapy," the perception that the use of risk models leads to unacceptable omission of potentially beneficial therapy; and (3) "Unnecessary Information," the opinion that information derived from risk models is not needed because physicians' decision making is already sound and they already know the information. CONCLUSIONS: Barriers to the use of risk models in clinical practice include physicians' perceptions that their experience is sufficient, that models may lead to omission of therapy in patients that may benefit from therapy, and that they already provide good care. Anticipating and overcoming these barriers may improve the adoption of precision medicine.
BACKGROUND: The foundation of precision medicine is the ability to tailor therapy based upon the expected risks and benefits of treatment for each individual patient. In a prior study, we implemented a software platform, ePRISM, to execute validated risk-stratification models for patients undergoing percutaneous coronary intervention and found substantial variability in the use of the personalized estimates to tailor care. A better understanding of physicians' perspectives about the use of individualized risk-estimates is needed to overcome barriers to their adoption. METHODS: In a qualitative research study, we conducted interviews, in-person or by telephone, with 27 physicians at 8 centers that used ePRISM until thematic saturation occurred. Data were coded using descriptive content analyses. RESULTS: Three major themes emerged among physicians who did not use ePRISM to support decision making: (1) "Experience versus Evidence," physicians' preference to rely upon personal experience and subjective assessments rather than objective risk estimates; (2) "Omission of Therapy," the perception that the use of risk models leads to unacceptable omission of potentially beneficial therapy; and (3) "Unnecessary Information," the opinion that information derived from risk models is not needed because physicians' decision making is already sound and they already know the information. CONCLUSIONS: Barriers to the use of risk models in clinical practice include physicians' perceptions that their experience is sufficient, that models may lead to omission of therapy in patients that may benefit from therapy, and that they already provide good care. Anticipating and overcoming these barriers may improve the adoption of precision medicine.
Authors: Derek P Chew; Ge Junbo; William Parsonage; Prafulla Kerkar; Vitaly A Sulimov; Matthew Horsfall; Sue Mattchoss Journal: Circ Cardiovasc Qual Outcomes Date: 2013-05-07
Authors: Craig E Strauss; Brandon R Porten; Ivan J Chavez; Ross F Garberich; Jeffrey W Chambers; Kenneth W Baran; Anil K Poulose; Timothy D Henry Journal: Circ Cardiovasc Qual Outcomes Date: 2014-11-04
Authors: Amit P Amin; Alok Bachuwar; Kimberly J Reid; Adnan K Chhatriwalla; Adam C Salisbury; Robert W Yeh; Mikhail Kosiborod; Tracy Y Wang; Karen P Alexander; Kensey Gosch; David J Cohen; John A Spertus; Richard G Bach Journal: J Am Coll Cardiol Date: 2013-03-26 Impact factor: 24.094
Authors: Seshu C Rao; Adnan K Chhatriwalla; Kevin F Kennedy; Carole J Decker; Elizabeth Gialde; John A Spertus; Steven P Marso Journal: J Am Coll Cardiol Date: 2013-03-07 Impact factor: 24.094
Authors: K L Lee; D B Pryor; F E Harrell; R M Califf; V S Behar; W L Floyd; J J Morris; R A Waugh; R E Whalen; R A Rosati Journal: Am J Med Date: 1986-04 Impact factor: 4.965
Authors: Adnan K Chhatriwalla; Carole Decker; Elizabeth Gialde; Delwyn Catley; Kathy Goggin; Katie Jaschke; Philip Jones; Dave deBronkart; Tony Sun; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2019-02
Authors: David M Kent; David van Klaveren; Jessica K Paulus; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg Journal: Ann Intern Med Date: 2019-11-12 Impact factor: 25.391
Authors: David M Kent; Jessica K Paulus; David van Klaveren; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg Journal: Ann Intern Med Date: 2019-11-12 Impact factor: 25.391
Authors: Amit P Amin; Samantha Miller; Brandon Rahn; Mary Caruso; Andrew Pierce; Katrine Sorensen; Howard Kurz; Alan Zajarias; Richard Bach; Jasvindar Singh; John M Lasala; Hemant Kulkarni; Patricia Crimmins-Reda Journal: J Am Heart Assoc Date: 2018-11-06 Impact factor: 5.501